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Detection of Gluten in Human Sera by an Enzyme Immunoassay: 
Comparison of Dermatitis Herpetiformis and Celiac Disease Patients 
with Normal Controls 
ALFRED T. L ANE, M.D., J . C LARK HUFF, M .D., AND WILLIAM L . W ESTON , M.D. 
University of Colorado Sch.ool of Medicine, Den ver, Colorado, U.S.A. 
W e h ave developed a triple sandwich enzyme immu-
n oassay to detect circula ting gluten in human ser a. With 
h uman ser a contain ing known amounts of added gluten 
as controls , the assay was sen sitive in the r ange of 0.75 
to 75 p.g of gluten per ml of serum. Forty-one contr ol 
subjects w ere compar ed to 21 p a tients with dermatitis 
herpetiformis and 11 p a tients with celia c disease. The 
dermatitis h erpetiformis and celiac disea se p atients h ad 
significant elevation of ser um gluten values over the 
contr ol subject s . Circula ting gluten antigen emia is a pre-
viously unrecognized feature which may b e important in 
under standing the p a thogen esis of dermatitis h erpeti-
formis and celiac disease. 
T he association between dietary wheat protein ingestion and 
dermatitis herpetiformis (DR ) has been observed since 1968 
[1]. T he wheat protein antigens felt to be responsible are gluten 
and particularly one subcomponent of glu ten, called gliadin, 
which is soluble in dilu te aqueous alcohol [2,3]. Gluten and 
gliadin have been shown to react equally with antibodies raised 
to either wheat protein [4]. Previous studies have shown the 
presence of antibodies to wheat proteins in sera of patients wi th 
DR [4-7]. Recently, Unsworth has demonstrated that the 
wheat protein gliadin binds to the reticulin-like fibers in the 
dermis of both normal and DR skin [8]. It has been suggested 
that wheat proteins bound to antibodies may circulate and bind 
to skin [9]. We repor t the detection of wheat protein in the sera 
of patients with dermatitis herpetiformis or with celiac disease 
(CD) by an enzyme immunoassay (ErA ). 
PATIENTS AND M ETHODS 
Patients 
Seru m was collected fro m 73 subjects with out regard to dietm·y 
wheat protein intake. Control sera' was evaluated from 41 healthy adul t 
volu nteers (mean age 30 yr) with no skin or bowel disease. T he control 
sera was compared to the sera of 21 patients wit h DH (mean age 45 yr) 
and 11 adults or children with CD (mean age 10 yr). T he DH patients 
a ll ha? p.ositive immu noflu orescent biopsies of skin for granular IgA 
depOSits 111 the dermal papilla. T he CD patients all had bowel disease 
re lated to wheat protein ingestion a nd villous atrophy documented by 
small bowel biopsy. . 
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Enzyme Immunoassay to Detect Wheat Protein in Sera 
A triple antibody sandwich E IA was developed to detect wheat 
protein in sera. This technique is detailed in T able 1. Ant ibodies to 
glu ten were generated in two a n.imal species, goat and rabbi t, Uu·ough 
bi-monthly immunization wi th a commercial wheat protein gliadin 
(lCN P hm-maceuticals, Inc., Clevela nd, OH) in complete Freunds ad-
juvan t. The sera fro m 3 different rabbits and 1 goat immunized to 
gliadin were eva luated by Ouch terlony double di ffusion analysis [10]. 
Each sera was placed in wells adjacen t to glu ten and gliadin a nt igens. 
An immunoprecipi tation line of identi ty for gluten a nd gliadin was seen 
in each serum evaluated. Goat serum was dilu ted in borate bu ffer for 
use in the enzyme immunoassay. The rabbi t IgG was separated from 
the serum by D EAE ion exchange chromatography. The eluate was 
concen trated to the original serum volume over a UM 10 (Amicon, 
Lexington, MA) membrane. The antibody t ite r of the anima l serum 
a nd immunoglobulin against glu ten was evaluated by EIA [4] a nd was 
found to be greater than 1:10,000 (to be published) . 
Flat-bottomed polystyrene plates (Linbro Flow Labs, H amden, CT) 
containing 96 wells were used for the assay as described in T able I and 
Fig 1. Controls for the assay were as follows: commercia l grade wheat 
prote in glu ten (S igma, St. Louis, MO) which contains gliadin and 
glu tenin was mixed in 0.05 M borate buffe red saline, pI-I 8.0, for 1 hr 
and then incubated at 40 C for 18 h1". The solu t ion was then centrifuged 
at 2,200 g fo r 10 min a nd the supernatant separated. The supernatan t 
was t hen fil tered into a sterile conta iner through a 0.2 p. (N alge, 
Rochester , NY) filter. A dye binding protein ana lysis (B io Had, Rich-
mond, CAl was done on the supernatant ell]. T he measw-ed protein 
content was consider ed to be the gluten conten t of the solu tion. The 
glu ten solu tion was further d ilu ted in 0.05 M borate bu ffered saline, pH 
8.0, to known concentrations of 750, 75 and 7.5 p.g of glu ten per ml of 
buffer solu tion. T o 900 p.l of normal huma n serum, 100 p.l a liquots of 
glu ten in borate buffe r or borate buffer was added, giving huma n serum 
controls wi th added glu ten concentrations of 75, 7.5 and 0.75 ~Lg of 
glu ten per ml of serum. Nine hundred p.J of sera dilu ted with 100 p.1 of 
borate bu ffered saline served as negative controls. 
A horseradish peroxidase conjugated immunoglobulin fraction of 
ra bbit an ti-sera against goat immunoglobulin (Miles-Yeda, Ltd ., Israel) 
was used to detect binding of goat ant ibodies to glu ten in the wells 
(Table I) . The color indicator substrate for horseradish perox.idase was 
prepared by the combination of 3 solu tions. Twenty-fi ve mg of 4-
aminoantipyrine m1d 810 mg of phenol were dissolved in distilled water 
to give a tota l volume of 50 m!. One ml of a solu tion containing 1.0 ml 
of 3 % hydrogen peroxide in 10 ml distilled water was added to 50 ml of 
0.2 M potassium phosphate bu ffer, pH 7.0. The final reagent was a 
combination of 42 ml of the phenol and 4-aminoantipyrine solu t ion 
added to 45 ml of the hydrogen peroxide potassium phosphate bu ffer 
solu tion. 
T he optical density (OD) at 492 nm of each well was read by an 8-
cha nnel photometer (Ti te rtek Mult iskan Flow Labs, Ha mden, CT) 
which recorded the 0 0 values within 60 seconds. T he OD was read on 
a scale from 0 to 2. The OD was blanked on an empty polystyrene 
plate. 
T he opt ima l concentrations of the various j·eagents was determined 
by checkerboard t it ration. T he assay was fu·st developed using known 
concentrations of glu ten in 0.05 M borate bu ffe red saline solution and 
then modified by the use of glu ten added to human sera. The glu ten 
was dissolved in the borate bu ffered saline because of the bu ffer's 
bacteriostatic proper ties [12] and the convenience of using a single 
buffe r in the assay. 
All serum samples, including controls with known amounts of glu ten, 
were placed in quadruplicate wells. The mean OD value of' the quad-
ruplicate samples was calculated. For each polystyrene plate t he mean 
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TABLE I. Details of EIA to detect wheat protein ill. sera 
1. 100 ILl of a solu tion containing 0.1% glutara ldehyde in 0.1 M cru'bon-
ate buffer , pH 9.6, was added to each well of a 96 well Linbro 
polystyrene TI at-bottomed plate and the plate was incubated at 
37°C for 2 hr. 
2. Three t imes each well was evacuated a nd then washed with ap-
proxima tely 300 ,.u of distilled water . After the fin al wash, each well 
was gently aspirated dry. 
3. 100 ILl of ra bbit ant i-gluten immunoglobulin dilu ted 1:200 in 0.1 M 
carbonate buffer , pH 9.6, was added to each well and t he plate was 
incubated for 18 hr at 4°C. 
4. Wells were emptied and washed 3 t imes as in step 2, however 0.05 
M borate buffered saline, pH 8.0, with 0.05% Tween 20 was used in 
place of distilled water . 
5. Sera to be tested was dilu ted 1:25 in 0.05 M borate buffered saline, 
pH 8.0, with 0.05% Tween 20. 100 ILl of the dilu ted sera was added 
to each well. The plate was incubated at 37°C for 90 min. 
6. Wells were emptied a nd washed 3 t imes as in step 4. 
7. 100 ILl of goat anti-glu ten sera, diluted 1:100 in 0.05 M borate 
buffered saline, pH 8.0, with 0.05% Tween 20 was added to each 
well. The plate was incubated 90 min at 37°C. 
8. Wells were emptied and washed 3 t imes as in s tep 4. 
9. 100 ILl of horseradish peroxidase conjugated rabbit immunoglobulin 
specific against goat immunoglobulin was dilu ted 1:200 in 0.05 M 
borate buffered saline, pH 8.0, with 0.05% Tween 20 a nd added to 
each well. The plate was incubated 60 min at 37°C. 
10. Wells were emptied a nd washed 3 times as in step 4. 
11. 100 ILl of color substrate was added to each well . 
12. After 1 hI' incubation at 37°C the OD in each well was read and 
recorded by an 8 channel photometer. 
OD va lues of the control samples with known amounts of added glu ten 
were plotted against the log of the glu ten concent ration (Fig 2). The 
curve generated was used to calculate serum glu ten concentra tions for 
sera tested on the same plate. The correlation coefficient of the gen-
era ted curve for glu ten concentration was greater than .95 for all plates 
tested. By repeat testing, the assay appeared to be sensitive in the 
r ange of 0.75 to 75 ILg of glu ten per ml of serum. For the purposes of 
statistical compru'ison among groups, calculated values ou tside of this 
range were used. Fisher's Exact T est and the 2-tailed t-test were used 
to compare the vru'ious groups. Rabbit and goat sera, prior to immu-
nization, contained no specific ant iglu ten activity and were used as 
negative contro ls for the assay. 
Two human sera with 4 known concentrations of glu ten added were 
compared on the same polystyrene plate on 3 separ ate occasions. The 
correlation coefficient of the generated curve for gluten concentration 
was greater than 0.96 for each sera. The serum availa ble in largest 
quantity was used to generate the standru'd CUj've for all subsequent 
assays. The percent error OD value, defined as the standard error of 
t he mean OD value divided by the mean OD value, was calculated for 
t he quadJ'llplicate samples on the same plate. The average value of the 
percent error for aU quadruplicate samples was 2.3%. T he day-to-day 
variabil ity of the assay was evaluated by repeatedly testing one control 
and one posit ive sera on different plates on 6 different days. The 
p ercent error of the control sera and posit ive sera were 3% and 2%, 
respectively. The positive control sera gave a greater value than the 
negative control sera on each day. The mean difference OD value 
between the 2 sera on 6 different days was evaluated with a 3.9% day-
to-day variation. 
RESULTS 
Figure 3 shows t he calculated gluten values for the 73 sera. 
By a 2-ta iled t-test, both DH and CD patients, as a group, 
showed significant elevation of mean serum gluten values. 
The data were evaluated for the number of subjects with 
calculated serum gluten values greater than the mean of the 
controls (0.278 Ilg/ml) plus 2 SD (SD = 0.27 Ilg/ml) (Table II) . 
This value, 0.812 Ilg of glu ten per ml of serum, is within the 
range of sensitivity of the assay. Comparing the DH and CD 
patients against the control subjects shows a highly significant 
difference by Fisher's Exact Test. 
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DISCUSSION 
A relationship of inlmunologically mediated human disease 
to dietary ant igens has often been postulated but rarely has it 
been shown that such antigens may enter the circulation rela-
tively intact antigenically and may be available to elicit im-
munological reactions in organ systems outside the gastrointes-
tinal tract. Wheat protein, especially the relatively insoluble 
protein complex, called glu ten, and its subcomponent soluble in 
dilu te alcohol, called gliadin, have been shown to be the dietary 
antigens responsible for precipitation of celiac disease, or non-
tropical sprue [2,3]. The appreciation that a skin disease, der-
matit is herpetiformis, is associated with CD and may also 
represent a disease related to dietary wheat protein, led to 
speculation that wheat protein antigens may be absorbed and 
lead to disease at sites removed from the gastrointestinal tract 
[9,13]. T he reports of circulating immune complexes in these 
diseases [14-16] and depression of serum complement after 
wheat protein ingestion [17] imply absorption and circulation 
of antigenic substances derived fro m wheat protein , but anti-
genemia has not been previously demonstrated in these condi-
tions. 
METHOD TO DETECT GLUTEN IN HUMAN SERA 
HRP RABBIT ANTI-GOAT IMMUNOGLOBIN 
GOAT ANTI - GLUTEN SERUM 
HUMAN SERUM CONTAINING GLUTEN 
RABBIT ANTI - GLUTEN IgG 
FIG 1. Schematic diagram of E IA to detect wheat prote in in sera. 
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FIG 2. Sample standru'd curve used to calculate serum gluten con-
centration. Values in pru'en theses ru'e those of the control samples with 
known amounts of added glu ten. 
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FIG 3. Calculated serum gluten concentration for 73 sera. Mean 
serum gluten values ± standard error of the mean for each group (/.1g/ 
ml) was 0.278 ± 0.042 control), 0.943 ± 0.295 (DH) and 36.05 ± 31.12 
(CD). The DH group (p < 0.01) and the CD group (p < 0.05) were 
significantly different from the control group by the 2-tailed t-test. 
Serum gluten values < 0.750 /.lg/ mJ were derived by calculations fTom 
the standard curve to allow statistical comparison among the groups. 
Individual sera containing < 0.750 /.lg/mJ of gluten, may, ill facL, contain 
no gluten since these values are less than the lower limit of sensitivity 
of the assay. 
TABLE n. Number of subjects with elevated serum gluten 
Control 
DH 
CD 
n 
41 
21 
11 
No. positive by EtA" 
2 
8 
6 
pi, 
0.003 
0.00] 
"Number positive by EIA ind.icate subjects with calculated serum 
gluten values greater than the mean of the controls plus 2 SD. 
b p-values were derived from a 2-tailed Fisher's Exact Test. 
The purposes of this study were to develop a sensitive assay 
for wheat protein antigens and to study the sera of patients 
with CD and DH for the presence of these antigens. We adapted 
an enzyme immun10assay for this purpose. With the use of the 
96 well microtiter plate and an 8-channel photometer for rapid 
reading and recording of optical density values, this assay 
aUowed easy study of many test sera in quadruplicate, inclusion 
of positive controls on each plate for generation of a standard 
curve, and study of many sera from normal control subjects. 
Because of the many layers in this sandwich technique (Fig 1), 
the optical density values generated in most wells were rela-
tively high. Despite the high backgTound, the precision of the 
assay was quite good, as demonstrated by the high correlation 
coefficients of the positive controls and the excellent agreement 
among the four wells used for specimens. The wheat protein 
antigen preparation used to generate the positive controls was 
crude, therefore, the true amounts of antigenic material in test 
sera must be less than the values calculated from our standal'd 
curve. 
The results of this study show clearly that the sera of patients 
with DH and CD, compared to those of normal control subjects, 
con tain antigenic material related to wheat protein. Both mean 
serum values and the number of sera with elevated values were 
significantly higher in these 2 di. eases. If sera had been obtained 
after dietary chaUenge with wheat protein rather than in a 
random manner, these differences might have been further 
magnified. 
It is possible that the higher levels of gluten found in CD and 
DH patients, in this study, reflect a simple diffusion of gluten 
across a damaged ,\ntestinal mucosa. As the enteropathy in CD 
is more severe than in DH, this would account for findings of 
higher serum gluten levels observed in CD patients. If wheat 
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protein antigens circulate in both patients with CD and those 
with DH, other differences must exist to explain the presence 
of skin disease in DH and the absence of skin disease in CD 
patients. 
CD is a chronic, symptomatic bowel disease characterized by 
diarrhea and malabsorption, whereas DH is a chronic, pruritic 
vesiculo-bullous skin disease associated with a largely asymp-
tomatic bowel disease histologicaUy similar to CD. Skin disease 
in DH patients may improve on a wheat protein-free diet, but 
the time required for response of the skin disease is far longer 
than fOJ' the bowel disease [18-21]. The role of wheat protein, 
if any, in the pathogenesis of the skin disease must involve 
other factors such as the differential immune response to wheat 
protein or skin changes allowing the interaction of circulating 
wheat proteins with skin. It would be of interest to know 
whether wheat proteins in serum change with short-term and 
long-term wheat protein-free diets in CD and DH patients and 
whether clinical improvement of skin disease correlated with 
decreases in serum wheat protein levels. 
Knowledge that wheat protein antigenemia may occm in 
patients with DH is a fact that may allow the following previ-
ously known clues concerning the pathogenesis of this disease 
to be tied together: gran ul aJ' IgA deposits at the dermal-epider-
mal junction in the skin [22] presence of serum antibodies to 
wheat protein antigens in the serum [4-7], gluten sensitivity 
[1], and the binding of gliadin to reticulin fibers in the skin at 
the same site as the IgA deposits [8]. When wheat protein is 
absorbed and circulates, it may bind to the skin, fix IgA anti-
body at that site, and thereby lead to a wheat protein-induced 
skin disease. Further support of this hypothesis will requi.re 
demonstration of specific IgA antibodies to wheat protein in 
these patients and the demonstration of wheat protein antigen 
and specific antibody in the skin. 
We thank Drs. Arnold Si lverman and Thomas Nixt, Department of 
Pediatrics for supplying sera from patients with celiac disease. 
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The Effect of Topical Drugs on Mouse Ear Epidermal Transglutaminase 
Activity 
LARRY D E YOUNG, PH.D. , AND S TEPHEN B ALLARON, B.S. 
Synlex Research, Palo A lto, California, U.S.A. 
The response of mouse ear. epidermal transglutamin-
ase to single applications of anthralin, r e tinoic acid (both 
50 p,g/ear) or fluocinolone acetonide (2 p,g/ ear) was de-
termined. Anthralin and retinoic acid caused inflamma-
tion and accumulation of epidermal protein and DNA, 
where a s fluocinolone acetonide resulted in ear thinning 
and decreased epidermal protein and DNA. Treat m ent 
with either anthralin or retinoic acid caused increases 
in absolute amounts of epidermal transglutaminase ac-
tivity/ear. Anthralin increased this parameter 70-100% 
above acetone-treated controls from 48 hr th.rough 7 
days. R etinoic acid-treated ears showed a slower initial 
increase but peaked at 4 times control level by 96 hr 
before returning to normal at 7 days. Fluocinolone ace-
tonide treatment had no effect on this parameter. The 
specific activity of epidermal trans glutaminase (total 
epidermal transglutaminase /total soluble epidermal 
protein) was decreased by r e tinoic acid treatment; w as 
maintained at normal levels by anth.ralin (except for the 
7-day point where it decrea sed 50%); and was dramati-
cally stimulated by fluocinolone ace tonide. In the la tter 
case, sp ecific a ctivity was more than 5 X cont rol by 96 
hr and still n ear this level at 7 days . Epidermal transglu-
taminase activity is a marker of differ entiation, and 
protein and DNA accumulation an indication of growth. 
Thus, at the doses studied, r e tinoic acid favors growth 
Manuscript received September 11, 1981; accepted fo r publication 
February 20, 1982. 
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over differ en t iation, anthralin m aintains a n or m al to 
near normal ratio of growth t o differen tia tion, and fluo-
cinoione acetonide strongly favors differentiation over 
growth. 
Epidermal transglutaminase (ETG) a marker enzyme of ter-
minal epidermal differentiation, is responsible for stabilization 
of the cornified envelope via formation of isopeptide bonds. 
Other than the repor t of Buxman and Wuepper [1] that histo-
chemically this enzyme apperu's to be absent in psoriatic lesions 
lacking a granulru' layer, little is known of its activity during 
either the pathogenesis or resolution of epidermal diseases. 
Whereas the effect of topical drugs on macromolecules ruld 
enzymes associated with epidermal prolifera tion has been stud-
ied in gJ.·eat detail, relatively little is known concerning their 
effect on epidermal differentiation. Histological evidence has 
long indicated that a restoration of normal epidermal differen-
t iation actually precedes the normalization of epidermal growth 
in psoriatic plaques [2,3]. Fwt hermore, acne, although associ-
ated with folliculru' hyperplasia, is cleru'ly a disease of abenant 
keratinization. We therefore feel it is important to understand 
the effect of known ant i-psoriasis and anti-acne agents on 
epidermal differentiation of normal and diseased skin. In this 
initial investigation, we present the effects of single applications 
of anthralin , fluocinolone acetonide (FA) and retinoic acid (RA) 
on nor mal mouse ear epidermal transglutaminase. In addition, 
to interpret om results over the background of biological activ-
ity of these agents, changes in ear thickness and epidermal 
DNA and protein have been monitored. 
MATERIALS AND METHODS 
Mice 
Female Swiss/ Webster mice 5-6 weeks old obtained fTom Simonsen 
Lab , Inc., Gilroy, CA, were kept under conventional conditions and 
used after 2 weeks acclimation. 
